Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Medicinal Chemistry
|
August 12, 2008
Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes
Santanu Bhattacharya, Padmaparna Chaudhuri
Chemistry, an Asian Journal
|
April 25, 2007
Metal-ion-mediated tuning of duplex DNA binding by bis(2-(2-pyridyl)-1H-benzimidazole)
Santanu Bhattacharya, Padmaparna Chaudhuri
The Journal of Organic Chemistry
|
February 20, 2007
An experimental and computational analysis on the differential role of the positional isomers of symmetric bis-2-(pyridyl)-1H-benzimidazoles as DNA binding agents
Padmaparna Chaudhuri, Bishwajit Ganguly, Santanu Bhattacharya
Nanotechnology
|
December 4, 2009
Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma
Padmaparna Chaudhuri, Shivani Soni, Shiladitya Sengupta
Journal of Medicinal Chemistry
|
April 21, 2007
Synthesis, DNA binding, and Leishmania topoisomerase inhibition activities of a novel series of anthra[1,2-d]imidazole-6,11-dione derivatives
Padmaparna Chaudhuri, Hemanta K Majumder, Santanu Bhattacharya
Cell Cycle (Georgetown, Tex.)
|
October 14, 2009
Targeting oncogenic signaling pathways by exploiting nanotechnology
Sudipta Basu, Padmaparna Chaudhuri, Shiladitya Sengupta
Bioconjugate Chemistry
|
June 12, 2010
Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition
Santanu Bhattacharya, Padmaparna Chaudhuri, Akash K Jain, et al.
ACS Nano
|
January 2, 2010
Shape effect of carbon nanovectors on angiogenesis
Padmaparna Chaudhuri, Rania Harfouche, Shivani Soni, et al.
ACS Nano
|
August 18, 2009
Fullerenol-cytotoxic conjugates for cancer chemotherapy
Padmaparna Chaudhuri, Abhimanyu Paraskar, Shivani Soni, et al.
Cancer Biology & Therapy
|
December 28, 2020
JAK-STAT inhibitor as a potential therapeutic opportunity in AML patients resistant to cytarabine and epigenetic therapy
Govind Babu, Padmaparna Chaudhuri, Manoj Rajappa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Medicinal Chemistry
|
August 12, 2008
Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes
Santanu Bhattacharya, Padmaparna Chaudhuri
Chemistry, an Asian Journal
|
April 25, 2007
Metal-ion-mediated tuning of duplex DNA binding by bis(2-(2-pyridyl)-1H-benzimidazole)
Santanu Bhattacharya, Padmaparna Chaudhuri
The Journal of Organic Chemistry
|
February 20, 2007
An experimental and computational analysis on the differential role of the positional isomers of symmetric bis-2-(pyridyl)-1H-benzimidazoles as DNA binding agents
Padmaparna Chaudhuri, Bishwajit Ganguly, Santanu Bhattacharya
Nanotechnology
|
December 4, 2009
Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma
Padmaparna Chaudhuri, Shivani Soni, Shiladitya Sengupta
Journal of Medicinal Chemistry
|
April 21, 2007
Synthesis, DNA binding, and Leishmania topoisomerase inhibition activities of a novel series of anthra[1,2-d]imidazole-6,11-dione derivatives
Padmaparna Chaudhuri, Hemanta K Majumder, Santanu Bhattacharya
Cell Cycle (Georgetown, Tex.)
|
October 14, 2009
Targeting oncogenic signaling pathways by exploiting nanotechnology
Sudipta Basu, Padmaparna Chaudhuri, Shiladitya Sengupta
Bioconjugate Chemistry
|
June 12, 2010
Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition
Santanu Bhattacharya, Padmaparna Chaudhuri, Akash K Jain, et al.
ACS Nano
|
January 2, 2010
Shape effect of carbon nanovectors on angiogenesis
Padmaparna Chaudhuri, Rania Harfouche, Shivani Soni, et al.
ACS Nano
|
August 18, 2009
Fullerenol-cytotoxic conjugates for cancer chemotherapy
Padmaparna Chaudhuri, Abhimanyu Paraskar, Shivani Soni, et al.
Cancer Biology & Therapy
|
December 28, 2020
JAK-STAT inhibitor as a potential therapeutic opportunity in AML patients resistant to cytarabine and epigenetic therapy
Govind Babu, Padmaparna Chaudhuri, Manoj Rajappa, et al.
Page
of 2